The Documentary Podcast Folgen

Israel faces growing international isolation over the shocking images of starvation in Gaza. Although Israel says there are no restrictions on aid deliveries – which it co-ordinates – or any starvation, charities warn the aid being allowed in is only a fraction of what is needed. The BBC is banned by Israel from reporting in Gaza but, in our conversations, doctors and journalists in the territory tell us how shortages of food, water and medical supplies are affecting them and their families. “We are not the same, this is not our shape, this is not our appearance,” Ghada, a journalist working in Gaza City tell us. We also hear from a medical student who shares her experiences of a typical day in Gaza and her hopes for the future. This episode of The Documentary, comes to you from BBC OS Conversations, bringing together people from around the world to discuss how major news stories are affecting their lives.

Bergen-Belsen Concentration Camp in Germany was the only camp liberated by the British Forces in April, 1945. Prior to that, over 50,000 people were murdered there. After liberation, the British Forces, alongside the American Jewish Joint Distribution Committee (AJDC) set up another camp about 2km away, the Bergen-Belsen Displaced Persons (DP) Camp, the largest DP camp in Europe, where over 2,000 babies were born. Known as ‘Bergen-Belsen Babies’, Susan Schwartz and Karen Lasky were two of the many born there and still hold the label ‘stateless’ after their families were eventually accepted and immigrated to Canada. On the 80th anniversary of the liberation, survivors and Bergen-Belsen Babies gather for the week, trying to fill in the gaps of what happened to their families and reflect on their childhoods. This episode of The Documentary, comes to you from Heart and Soul, exploring personal approaches to spirituality from around the world.

Could AI cure cancer using nature's DNA? A London tech firm, Basecamp Research, harvests genetic information from organisms and microbes around the world. Its genome database - the world's biggest - will help supercomputers to create new products, from detergents to medicines. It's a bewildering new frontier, and it comes with big questions: who should own this valuable information? Who should benefit? And what could it unleash?